Lasering Mixto SX in Java Development barcode 39 in Java Lasering Mixto SX web pages barcode

Lasering Mixto SX use none none writer toinsert none with nonepdf-417 Similar to the p none none receding system, a recently introduced 10,600-nm continuous-wave laser (Slim Evolution, Lasering Inc.) has been tted with a novel scanning. .NET CF 64 . Fractionated CO2 Laser 281 handpiece (Mixto SX), allowing for a scanned pattern of 300- m spots to be laid down in an area ranging from 6 6 mm to 20 20 mm. According to white papers, the depth of the spots varies from 20 to 500 m, treating from 20 to 100% of the treatment area. The user of the device controls the depth of penetration through the manipulation of two factors: the output wattage of the continuous wave (CW) laser and the SX index, which represents the dwell time (range 2.

5-16 ms) of the CW laser at each treatment spot, with a longer dwell time resulting in a deeper depth of injury. Patients reportedly tolerate treatments without the anesthesia, though this would likely indicate that the device was used to deliver more super cial treatments than some of the other devices. The histologic correlation between the SX index and lesional depth has not been elucidated but, once available, will make the results with this device much more predictable.

As with the Lumenis device, the Mixto SX device is built on a standard CO2 platform, which allows for the exibility of using a fully ablative mode, when required, as well as fractional treatment.. is marketed as a none none minimal-downtime device at the parameters outlined, which is in line with the relatively low energy pulses utilized. As with many of the other devices built on continuous-wave CO2 platforms, the DOT laser offers a full range of both standard and fractional handpieces..

ER:YAG LASER-BASED SYSTEMS Sciton ProFractional Lutronic eCO2 The eCO2 device none none (Lutronic Inc.) is another fractionally delivered CO2 laser built on a standard platform. Using a 30-W, continuous-wave laser as its power source, this device is capable of delivering spots in a variety of sizes, akin to the Lumenis device described previously.

The sizes available are a truly fractional 120 m, a midrange 300 m, and a 1,000- m spot, as well. Pulse energies vary from 2 to 240 mJ, and this device can deliver anywhere from 25 to 400 spots/cm2 . Using the 120- m spot size, the manufacturer claims that its initial internal studies have shown possible treatment depths up to 2.

4 mm into the dermis. Unique to this device is the ability to change the pattern of spot delivery from a uniform grid pattern to a random pattern within the 14 14 mm treatment zone. This feature is termed controlled chaos technology and is purported to reduce bulk heating of the dermal tissue.

. SmartXide Dermal Optical Thermolysis Therapy The SmartXide De none none rmal Optical Thermolysis (DOT) laser (Eclipsemed Inc.) is again based on a 30-W, continuouswave CO2 laser, which delivers laser energy into the tissue in middle-width 350- m spots. The treatment pattern is 15 15 mm, and rather than varying the energy per pulse or the density of spots, with this device, the usercontrolled parameters are the dwell time of the laser at each position (from 0.

2 to 2.0 ms) and the pitch between spots (0.2 1.

0 mm). Per the manufacturer s literature, the maximal energy per pulse is 60 mJ. This device is reported by the manufacturer to be effective in improving skin texture, ne and deep wrinkles, and acne scars.

This device. The Sciton ProFr actional laser system (Sciton Inc.) is a new fractional handpiece designed to operate on their 2,940nm Er:YAG Pro le platform. This device has a scanningtype handpiece with a 2 2 cm window within which the user can control the amount of skin surface treated with 250- m spots, from 1.

5 to 60% of the total treatment eld. The treatment area is selectable between 6 mm2 and 2 cm2 . In theory, the ProFractional handpiece should be capable of delivering ablative columns to depths over 1 mm.

As this is a modi cation of an already existing device, controlled trials were not required before the ProFractional was released to market. However, early white papers detailing clinical experience with this device show that most patients are being treated with energies resulting in depths of penetration from 100 to 200 m and approximately 10% coverage of the skin. Patients generally receive one to two treatments at these settings.

One of the unique aspects of this device is that the user can select the desired depth of penetration for the intended treatment, and the device will then select the appropriate uence to be delivered to the skin. Most of the early experience with the device is for general photorejuvenation of the skin, but research on its use for acne scarring at higher energies and depths of penetration is in progress. As most of the treatments with this device are more super cial in nature, physicians employing the ProFractional have noted that topical anesthesia with or without adjunctive cold air cooling has been adequate for pain control.

For 100- to 200- m treatment depths, downtime estimates are reported to be on the order of one to two days of mild erythema, which can be covered with makeup after approximately twentyfour hours. Ongoing research is also being conducted using a combination treatment with the MicroLaserPeel procedure, whereby a fully ablative Er:YAG laser is used to ablate the uppermost 50 m of epidermis, followed by ProFractional treatment at approximately 100- to 200- m depth; reports have shown promising results in treating dyschromia and ne lines with minimal discomfort and downtime, although the dual treatment is sure to prolong healing..

Copyright © . All rights reserved.